1. Home
  2. IOVA vs STBA Comparison

IOVA vs STBA Comparison

Compare IOVA & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$47.85

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
STBA
Founded
2007
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
IOVA
STBA
Price
$4.08
$47.85
Analyst Decision
Buy
Hold
Analyst Count
10
6
Target Price
$9.00
$43.00
AVG Volume (30 Days)
12.1M
196.8K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
3.29%
EPS Growth
14.84
2.35
EPS
N/A
0.94
Revenue
N/A
N/A
Revenue This Year
$47.74
$10.20
Revenue Next Year
$40.31
$4.14
P/E Ratio
N/A
$50.15
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$34.01
52 Week High
$5.63
$47.50

Technical Indicators

Market Signals
Indicator
IOVA
STBA
Relative Strength Index (RSI) 53.47 69.61
Support Level $2.07 $42.52
Resistance Level $4.35 N/A
Average True Range (ATR) 0.36 0.96
MACD -0.02 0.26
Stochastic Oscillator 40.45 98.58

Price Performance

Historical Comparison
IOVA
STBA

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.

Share on Social Networks: